Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Categories:
3D Cell Culture , Transfection, Cell Lines and Primary Cancer Cells
Authors:
Aditya Mithal, Amalia Capilla,Dar Heinze, Andrew Berical, Carlos Villacorta-Martin, Marall Vedaie, Anjali Jacob, Kristine Abo, Aleksander Szymaniak, Megan Peasley, Alexander Stuffer, John Mahoney, Darrell N. Kotton, Finn Hawkins, and Gustavo Mostoslavsky
In:
Nat Commun. (2020) 11: 215
Categories:
Classical Media and Reagents, Serum-free and Speciality Media
Authors:
Chal J, Al Tanoury Z, Hestin M, Gobert B, Aivio S, Hick A, Cherrier T, Nesmith AP, Parker KK, Pourquié O
In:
Nat Protocols (2016) 11(10): 1833-50
Categories:
Authors:
Jia Liu, Thomas Gaj, Yifeng Yang, Nan Wang, Sailan Shui, Sojung Kim, Chidananda Nagamangala Kanchiswamy, Jin-Soo Kim, Carlos F Barbas III
In:
Nat Protocols (2015) 10(11): 1842-59
Categories:
Transfection
Authors:
Kim S, Kim D, Cho SW, Kim J, Kim JS
In:
Genome Res (2014) 24(6): 1012-9
Categories:
Primary Cells and Media
Authors:
Deuse T, Seifert M, Phillips N, Fire A, Tyan D, Kay M, Tsao PS, Hua X, Velden J, Eiermann T, Volk HD, Reichenspurner H, Robbins RC, Schrepfer S.
In:
Circulation (2011) 124(11): ePub
Categories:
Primary Cells and Media, Classical Media and Reagents, Serum-free and Speciality Media
Authors:
James CO, Huang MB, Khan M, Garcia-Barrio M, Powell MD, Bond VC
In:
J Virol (2004) 78(6): 3099-109